Plasma Steroid Profiling in Patients With Adrenal Incidentaloma.
Berke K, Constantinescu G, Masjkur J, Kimpel O, Dischinger U, Peitzsch M, Kwapiszewska A, Dobrowolski P, Nölting S, Reincke M, Beuschlein F, Bornstein SR, Prejbisz A, Lenders JWM, Fassnacht M, Eisenhofer G.
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1181-e1192. doi: 10.1210/clinem/dgab751.
PMID:34665854
Pharmacology of vorozole.
Wouters W, Van Ginckel R, Krekels M, Bowden C, De Coster R.
[Update on the risk of corticosterone therapy in combination with abiraterone acetate during the COVID-19 pandemic].
Rozet F, Mongiat-Artus P, Ploussard G, Rouprêt M, Cacoub P, Fournier G, Mathieu R.
Prog Urol. 2021 Apr;31(5):243-244. doi: 10.1016/j.purol.2020.12.002. Epub 2020 Dec 10.
PMID:33468416
Host endocrine responses during tumor growth.
Besedovsky H, del Rey A, Normann SJ.
Prog Clin Biol Res. 1989;288:203-13.
PMID:2654951
Brainstem prolactin-releasing peptide contributes to cancer anorexia-cachexia syndrome in rats.
Navarro I Batista K, Schraner M, Riediger T.
Neuropharmacology. 2020 Dec 1;180:108289. doi: 10.1016/j.neuropharm.2020.108289. Epub 2020 Sep 2.
PMID:32890590
Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.
Borges KS, Pignatti E, Leng S, Kariyawasam D, Ruiz-Babot G, Ramalho FS, Taketo MM, Carlone DL, Breault DT.
Oncogene. 2020 Jul;39(30):5282-5291. doi: 10.1038/s41388-020-1358-5. Epub 2020 Jun 19.
PMID:32561853
Aldosterone-, corticosterone- and cortisol-secreting adrenocortical carcinoma in a dog: case report.
Machida T, Uchida E, Matsuda K, Hirayama K, Yoshii K, Takiguchi M, Taniyama H.
J Vet Med Sci. 2008 Mar;70(3):317-20. doi: 10.1292/jvms.70.317.
PMID:18388437
P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.
Batisse-Lignier M, Sahut-Barnola I, Tissier F, Dumontet T, Mathieu M, Drelon C, Pointud JC, Damon-Soubeyrand C, Marceau G, Kemeny JL, Bertherat J, Tauveron I, Val P, Martinez A, Lefrançois-Martinez AM.